Close Menu

It's Not That Simple

Thanks to a new test, checking for genetic abnormalities in a fetus is easier and less invasive — but there's a downside, says Nature News' Erika Check Hayden. Sequenom's new MaterniT21 Down syndrome test requires only a small sample of the mother's blood, and is only one of several similar tests expected to hit the market soon, Hayden says. While such tests spare women from amniocentesis or other invasive procedures, doctors say they pose other problems, Hayden says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.